RAB19B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-13188
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (95%), Rat (97%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against Recombinant Protein corresponding to amino acids: LIGNKCDLWEKRHVLFEDACTLAEKYGLLAVLETSAKES
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for RAB19B Antibody
Immunohistochemistry-Paraffin: RAB19B Antibody [NBP2-13188]
Immunohistochemistry-Paraffin: RAB19B Antibody [NBP2-13188] Staining of human rectum shows strong cytoplasmic positivity in glandular cells.Applications for RAB19B Antibody
Application
Recommended Usage
Immunohistochemistry
1:50 - 1:200
Immunohistochemistry-Paraffin
1:50 - 1:200
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: RAB19B
Alternate Names
RAB19, member RAS oncogene family, RAB19BGTP-binding protein RAB19B, ras-related protein Rab-19
Gene Symbol
RAB19
Additional RAB19B Products
Product Documents for RAB19B Antibody
Product Specific Notices for RAB19B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...